pISSN 1226-6051
eISSN 2508-786X

Table. 3.

Table. 3.

Characteristics of RA patients by pharmacotherapy group before and after inverse probability of treatment weighting (IPTW)

Types of pharmacotherapyCharacteristics of patientsBefore weighting, N (%)After weighting, N (%)

non-pharmacotherapypharmacotherapynon-pharmacotherapypharmacotherapy
tDMARDAge56.54 (15.97)a56.43 (14.24)a56.53 (17.49)a56.56 (35.12)a

SexMale10,001 (30.8)1,388 (4.3)10,478 (17.0)10,493 (17.0)
FemaleX17,036 (52.4)4,091 (12.6)20,394 (33.0)20,387 (33.0)

Insurance typeMedical25,121 (77.3)5,169 (15.9)30,289 (46.6)30,283 (46.5)
Medicaid1,823 (5.6)298 (0.9)2,121 (3.2)2,139 (3.3)
Veterans93 (0.3)12 (< 0.1)105 (0.2)105 (0.2)

Total27,037 (83.2)5,479 (16.8)32,515 (50.0)32,527 (50.0)

Biologic agentAge56.54 (15.97)a43.53 (13.80)a56.41 (16.11)a55.79 (161.0)a

SexMale10,001 (36.6)211 (0.8)10,212 (18.8)9539.(17.6)
Female17,036 (62.4)62 (0.2)17,098 (31.6)17,328 (32.0)

Insurance typeMedical25,121 (92.0)252 (0.4)25,373 (46.8)25,594 (47.2)
Medicaid1,823 (6.7)19 (< 0.1)1842 (3.4)1,204 (2.2)
Veterans93 (0.3)2 (< 0.1)95 (0.2)69 (0.1)

Total27,037 (99.0)273 (1.0)27,310 (50.4)26,867 (49.6)

mean (standard deviation)

RA: rheumatoid arthritis, tDMARD: traditional disease-modifying antirheumatic drugs

Korean J Clin Pharm 2019;29:109-14 https://doi.org/10.24304/kjcp.2019.29.2.109
© 2019 Korean J Clin Pharm